A drug designed to fight anemia appears to double the risk of stroke in patients with diabetes and kidney disease without substantially improving their quality of life, a new study finds.
Darbepoetin alfa, marketed as Aranesp and known as an erythropoiesis-stimulating agent (ESA), is often prescribed...
... read Anemia Drug May Raise Stroke Risk in Kidney Patients
Similar Topics: anemia > Harvard > kidney > medication > prevention > stroke